Finasteride/tadalafil

Finasteride/tadalafil, sold under the brand name Entadfi, is a fixed-dose combination medication used for the treatment of benign prostatic hyperplasia (BPH).^[1][2][3] It contains finasteride and tadalafil.^[1] It is taken by mouth.^[1]

Finasteride/tadalafil

Combination of
Finasteride	5α-reductase inhibitor
Tadalafil	Phosphodiesterase 5 (PDE5) inhibitor
Clinical data
Trade names	Entadfi
AHFS/Drugs.com	Micromedex Detailed Consumer Information
License data	US DailyMed: Finasteride and tadalafil
Routes of administration	By mouth
ATC code	G04CB51 (WHO)
Legal status
Legal status	US: ℞-only[1]
Identifiers
KEGG	D12486

It was approved for medical use in the United States in December 2021.^[1][4]

Medical uses

Finasteride/tadalafil is indicated to treat benign prostatic hyperplasia (BPH) in men.^[1]